利润表（安科生物）
| 上市前/上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 | 上市后 |
| 报表类型 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 | 合并报表 |
| 一、营业总收入(元) | 1,921,280,101.12 | 1,298,815,000.98 | 656,092,096.17 | 2,865,752,059.95 | 2,021,384,056.69 | 1,287,279,354.46 | 594,174,209.84 |
| 营业收入(元) | 1,921,280,101.12 | 1,298,815,000.98 | 656,092,096.17 | 2,865,752,059.95 | 2,021,384,056.69 | 1,287,279,354.46 | 594,174,209.84 |
| 二、营业总成本(元) | 1,268,341,322.03 | 842,210,918.23 | 412,632,143.81 | 1,930,498,177.72 | 1,257,752,219.43 | 826,263,354.01 | 377,413,240.03 |
| 营业成本(元) | 427,566,812.85 | 282,541,657.51 | 148,033,750.97 | 620,344,181.63 | 439,768,034.42 | 286,430,556.10 | 146,678,486.58 |
| 研发费用(元) | 128,568,208.02 | 81,389,550.12 | 37,176,848.42 | 254,679,885.17 | 152,939,567.06 | 100,932,188.28 | 35,377,092.33 |
| 营业税金及附加(元) | 16,291,120.14 | 11,332,785.56 | 5,616,948.63 | 24,611,653.19 | 17,107,252.28 | 11,437,305.18 | 5,209,625.10 |
| 销售费用(元) | 569,872,415.82 | 381,236,082.38 | 171,824,874.82 | 831,323,114.06 | 518,385,202.05 | 345,361,759.01 | 149,534,885.84 |
| 管理费用(元) | 127,501,408.32 | 86,836,985.52 | 50,396,761.16 | 203,348,567.20 | 131,910,705.15 | 83,547,159.08 | 41,645,710.60 |
| 财务费用(元) | -1,458,643.12 | -1,126,142.86 | -417,040.19 | -3,809,223.53 | -2,358,541.53 | -1,445,613.64 | -1,032,560.42 |
| 其中：利息费用(元) | 2,086,517.92 | 1,442,672.30 | 870,396.37 | 1,873,835.14 | 1,240,381.83 | 776,489.16 | 364,793.49 |
| 其中：利息收入(元) | 4,234,648.56 | 2,892,453.53 | 1,511,862.47 | 5,894,033.33 | 4,688,003.73 | 3,008,161.11 | 1,619,883.04 |
| 三、其他经营收益 | |||||||
| 加：公允价值变动收益(元) | -2,566,129.73 | 1,210,799.94 | 3,497,728.11 | -411,050.27 | 2,505,377.29 | -1,858,898.41 | 564,009.72 |
| 加：投资收益(元) | 14,703,993.65 | 7,254,879.77 | 1,303,243.94 | -4,742,482.53 | -2,947,595.00 | 1,906,115.43 | 431,079.56 |
| 其中：对联营企业和合营企业的投资收益(元) | -16,044,207.41 | -11,560,655.05 | -5,311,620.40 | -31,707,315.79 | -19,541,236.95 | -11,458,392.75 | -4,875,034.26 |
| 资产处置收益(元) | 925,226.73 | 1,090,558.93 | 995,960.42 | 120,701.82 | -380.24 | -1,594.35 | - |
| 资产减值损失(元) | -359,410.89 | -359,410.89 | -68,675.76 | -17,483,675.33 | -9,215.23 | 91,055.49 | 36,723.02 |
| 信用减值损失(元) | 4,557,420.96 | 2,712,977.56 | 1,060,706.26 | -20,154,961.80 | -6,324,908.97 | -3,143,782.58 | -1,687,340.60 |
| 其他收益(元) | 29,164,487.19 | 24,482,956.08 | 7,351,748.22 | 31,396,697.10 | 11,618,340.73 | 5,606,580.91 | 3,804,539.51 |
| 四、营业利润(元) | 699,364,367.00 | 492,996,844.14 | 257,600,663.55 | 923,979,111.22 | 768,473,455.84 | 463,615,476.94 | 219,909,981.02 |
| 加：营业外收入(元) | 712,568.27 | 562,792.30 | 20,000.00 | 65,178.53 | 30,570.51 | 8,733.41 | 3,733.34 |
| 减：营业外支出(元) | 1,801,598.81 | 1,541,555.00 | 1,398.93 | 4,114,683.87 | 728,513.25 | 115,858.90 | 49,841.29 |
| 五、利润总额(元) | 698,275,336.46 | 492,018,081.44 | 257,619,264.62 | 919,929,605.88 | 767,775,513.10 | 463,508,351.45 | 219,863,873.07 |
| 减：所得税费用(元) | 98,360,204.89 | 68,247,433.27 | 35,676,921.67 | 61,340,614.31 | 103,155,035.57 | 61,644,850.90 | 31,012,990.63 |
| 六、净利润(元) | 599,915,131.57 | 423,770,648.17 | 221,942,342.95 | 858,588,991.57 | 664,620,477.53 | 401,863,500.55 | 188,850,882.44 |
| (一)按经营持续性分类 | |||||||
| 持续经营净利润(元) | 599,915,131.57 | 423,770,648.17 | 221,942,342.95 | 858,588,991.57 | 664,620,477.53 | 401,863,500.55 | 188,850,882.44 |
| (二)按所有权归属分类 | |||||||
| 归属于母公司股东的净利润(元) | 589,719,954.61 | 416,132,684.80 | 217,749,931.36 | 847,229,426.30 | 654,414,603.25 | 396,356,304.70 | 185,618,139.71 |
| 少数股东损益(元) | 10,195,176.96 | 7,637,963.37 | 4,192,411.59 | 11,359,565.27 | 10,205,874.28 | 5,507,195.85 | 3,232,742.73 |
| 扣除非经常性损益后的净利润(元) | 555,425,494.45 | 390,202,387.04 | 204,934,342.97 | 809,324,373.22 | 630,669,195.66 | 383,064,864.35 | 178,156,883.51 |
| 七、每股收益 | |||||||
| 一、基本每股收益(元) | 0.35 | 0.25 | 0.13 | 0.51 | 0.39 | 0.24 | 0.11 |
| 二、稀释每股收益(元) | 0.35 | 0.25 | 0.13 | 0.51 | 0.39 | 0.24 | 0.11 |
| 九、综合收益总额(元) | 599,915,131.57 | 423,770,648.17 | 221,942,342.95 | 858,588,991.57 | 664,620,477.53 | 401,863,500.55 | 188,850,882.44 |
| 归属于母公司所有者的综合收益总额(元) | 589,719,954.61 | 416,132,684.80 | 217,749,931.36 | 847,229,426.30 | 654,414,603.25 | 396,356,304.70 | 185,618,139.71 |
| 归属于少数股东的综合收益总额(元) | 10,195,176.96 | 7,637,963.37 | 4,192,411.59 | 11,359,565.27 | 10,205,874.28 | 5,507,195.85 | 3,232,742.73 |
| 公告日期 | 2024-10-25 | 2024-08-28 | 2024-04-26 | 2024-03-28 | 2023-10-25 | 2023-08-24 | 2023-04-28 |
| 审计意见(境内) | 标准无保留意见 | ||||||
| 原始财报文件下载 | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) | 下载财报(PDF) |
| 上市前/上市后 |
| 报表类型 |
| 一、营业总收入(元) |
| 营业收入(元) |
| 二、营业总成本(元) |
| 营业成本(元) |
| 研发费用(元) |
| 营业税金及附加(元) |
| 销售费用(元) |
| 管理费用(元) |
| 财务费用(元) |
| 其中：利息费用(元) |
| 其中：利息收入(元) |
| 三、其他经营收益 |
| 加：公允价值变动收益(元) |
| 加：投资收益(元) |
| 其中：对联营企业和合营企业的投资收益(元) |
| 资产处置收益(元) |
| 资产减值损失(元) |
| 信用减值损失(元) |
| 其他收益(元) |
| 四、营业利润(元) |
| 加：营业外收入(元) |
| 减：营业外支出(元) |
| 五、利润总额(元) |
| 减：所得税费用(元) |
| 六、净利润(元) |
| (一)按经营持续性分类 |
| 持续经营净利润(元) |
| (二)按所有权归属分类 |
| 归属于母公司股东的净利润(元) |
| 少数股东损益(元) |
| 扣除非经常性损益后的净利润(元) |
| 七、每股收益 |
| 一、基本每股收益(元) |
| 二、稀释每股收益(元) |
| 九、综合收益总额(元) |
| 归属于母公司所有者的综合收益总额(元) |
| 归属于少数股东的综合收益总额(元) |
| 公告日期 |
| 审计意见(境内) |
| 原始财报文件下载 |
Showing 1 to 42 of 42 entries